A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression

Keyphrases

• MRNA Expression 100%
• Prognostic Biomarker 100%
• Triple-negative Breast Cancer 100%
• KLK11 100%
• KLK10 100%
• Tumor Tissue 33%
• Breast Cancer Patients 33%
• Protease 33%
• Expression Level 33%
• Breast Cancer Subtypes 33%
• Patient Prognosis 33%
• Tumor 16%
• Growth Factors 16%
• Quantitative PCR 16%
• MRNA Level 16%
• Clinical Significance 16%
• Severe Disease 16%
• Therapeutic Potential 16%
• Cox Regression Analysis 16%
• Signaling Pathway 16%
• Oncogenesis 16%
• Breast Cancer 16%
• Clinical Factors 16%
• Residual Tumor 16%
• Patient Cohort 16%
• Therapeutic Target 16%
• Healthy Donors 16%
• Targets for Therapy 16%
• Chemokines 16%
• Tumor Mass 16%
• Metastatic Breast Cancer 16%
• Lymph Node Status 16%
• Kallikrein-related Peptidases 16%
• Extracellular Matrix Degradation 16%
• Coordinate Expression 16%
• Breast Cancer Progression 16%
• Expression Mode 16%
• Aggressive Breast Cancer 16%
• Multivariable Cox Regression 16%
• Extracellular Matrix Modulation 16%
• Matrix Release 16%
• Unfavorable Prognostic Factors 16%
• Proteolytic Networks 16%

Biochemistry, Genetics and Molecular Biology

• Messenger RNA 100%
• Protease 66%
• Real-Time Polymerase Chain Reaction 33%
• Carcinogenesis 33%
• Chemokine 33%
• Cytokine 33%
• Kallikrein 33%
• Peptidase 33%
• Growth Factor 33%